---
audienceLevel: patient
cancerTypes:
- general
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: Treosulfan - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/treosulfan
version: v1
---

# Treosulfan - NCI

# Treosulfan

Placeholder slot

(TREE-oh-SUL-fan)

This page contains brief information about treosulfan
and a collection of links to more information about the use of
this drug, research results, and ongoing clinical trials.

US Brand Name(s)

Grafapex

FDA Approved

Yes

[FDA label information for this drug is available at DailyMed.](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2d06b03c-17aa-0492-e063-6294a90abd8f&audience=consumer)

## Use in Cancer

Treosulfan
is approved to be given with [fludarabine phosphate](/Common/PopUps/popDefinition.aspx?id=613209&version=Patient&language=English) before a donor [blood stem cell](/Common/PopUps/popDefinition.aspx?id=765906&version=Patient&language=English) [transplant](/Common/PopUps/popDefinition.aspx?id=270732&version=Patient&language=English) in adults and children aged 1 year and older with:

- **[acute myeloid leukemia](/Common/PopUps/popDefinition.aspx?id=46347&version=Patient&language=English)**
- **[myelodysplastic syndrome](/Common/PopUps/popDefinition.aspx?id=45266&version=Patient&language=English)**

Treosulfan
is also being studied in the treatment of other types of
cancer.

## More About Treosulfan

[Definition from the NCI Drug Dictionary](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/39720) - Detailed scientific definition and other names for this drug.

## Clinical Trials Accepting Patients

[Find Clinical Trials for Treosulfan](https://www.cancer.gov/research/participate/clinical-trials/intervention/C1257) - Check for trials from NCI's list of cancer clinical trials now accepting patients.
